The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enable...
Main Authors: | Marko Roblek, Julia Bicher, Merel van Gogh, Attila György, Rita Seeböck, Bozena Szulc, Markus Damme, Mariusz Olczak, Lubor Borsig, Daria E. Siekhaus |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.777634/full |
Similar Items
-
The lysosomal transporter MFSD1 is essential for liver homeostasis and critically depends on its accessory subunit GLMP
by: David Massa López, et al.
Published: (2019-10-01) -
MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response
by: Bin Zhang, et al.
Published: (2023-10-01) -
Loss of mfsd8 alters the secretome during Dictyostelium aggregation
by: Robert J. Huber, et al.
Published: (2023-12-01) -
The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases
by: Liqiong Ding
Published: (2024-06-01) -
Maculopathy and adult‐onset ataxia in patients with biallelic MFSD8 variants
by: Sigurd Dobloug, et al.
Published: (2024-08-01)